Company / Depreciation & Amortization
Intellia Therapeutics, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$9.8M
FY2025
5-year range
$6.9M / $10.3M
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
#112 of 135
Health Care
What the data says
Intellia Therapeutics, Inc.'s depreciation & amortization of $10M is lower than 83% of companies in the Health Care sector (FY2025). Increased from $9M to $10M over the past 2 years.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +9.1%.
Increased from $9M to $10M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 135This company $9.8M Sector average $334.5M
▼
-97.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.1%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 5.0% year-over-year.
- Ranks #112 out of 135 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.8M | -5.0% |
| FY2024 | $10.3M | +14.6% |
| FY2023 | $9.0M | +18.5% |
| FY2022 | $7.6M | +9.9% |
| FY2021 | $6.9M | +9.2% |
| FY2020 | $6.3M | +13.0% |
| FY2019 | $5.6M | +25.2% |
| FY2018 | $4.5M | +49.1% |
| FY2017 | $3.0M | +171.2% |
| FY2016 | $1.1M | +236.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026